Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

rATG Versus rATG Combined With IVIG Induction Immunosuppression in HLA Incompatible Transplantation

NCT04302805 is registered in ClinicalTrials.gov with Institute for Clinical and Experimental Medicine as lead sponsor.

NCT NCT04302805
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04302805 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
rATG Versus rATG Combined With IVIG Induction Immunosuppression in HLA Incompatible Transplantation
Lead sponsor
Institute for Clinical and Experimental Medicine
Phase
Phase 3
Overall status
Completed
Start date
July 27, 2020
Completion date
June 15, 2024
Enrollment
17 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

kidney transplantation